Understanding the immune response after acetaminophen overdose
The Immune Response After Drug Induced Hepatotoxicity
This study is looking at how the immune system helps heal the liver after an acetaminophen overdose, which can cause serious liver problems, and it aims to find better ways to support recovery for people affected by this issue.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10997388 on NIH RePORTER |
What this research studies
This research investigates how the immune system reacts to liver damage caused by acetaminophen overdose, which is a leading cause of acute liver failure. The study aims to explore the role of immune cells in the healing process and how certain proteins can enhance liver recovery. By examining the timing and effectiveness of current treatments, the research seeks to identify new therapeutic strategies that could improve patient outcomes. The approach includes both animal experiments and human studies to gather comprehensive data on immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced an acetaminophen overdose or are at risk of acute liver failure due to acetaminophen use.
Not a fit: Patients who have not taken acetaminophen or those with liver conditions unrelated to acetaminophen overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients suffering from acetaminophen-induced liver injury, potentially enhancing recovery and reducing mortality rates.
How similar studies have performed: Previous research has shown promise in understanding immune responses in liver injury, but this specific approach focusing on acetaminophen overdose is relatively novel.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Ramachandran, Anup — University of Kansas Medical Center
- Study coordinator: Ramachandran, Anup
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.